The Train2Target Scientific Advisory Board (SAB) consists external experts from academic, industry and regulatory with the aim of bringing independent advice and additional viewpoints to the Train2Target research and training programme.
- Advising the Supervisory Board on both, scientific and training related matters
- Reviweing the progress reports delivered by the ESRs
- Participating in open discussions with Train2Target researchers
Chair
Prof Miguel Vicente, Bacteriology & Applied Microbiology Division, Centro Nacional de Biotechnologia, Spain.
Background in molecular genetics analysis of the divisome, the machinery used by the bacteria to proliferate, and in its reconstruction using a bottom-up Synthetic Biology approach. Experienced coorinator of several EC-funded projects on bacterial proliferation and antimicrobial discovery; curretly active in the ENABLE consortium (European Gram Negative AntiBacterial Engine), an IMI initiative to advance prospective antibiotic hits into clinical tests.
Background in molecular genetics analysis of the divisome, the machinery used by the bacteria to proliferate, and in its reconstruction using a bottom-up Synthetic Biology approach. Experienced coorinator of several EC-funded projects on bacterial proliferation and antimicrobial discovery; curretly active in the ENABLE consortium (European Gram Negative AntiBacterial Engine), an IMI initiative to advance prospective antibiotic hits into clinical tests.
Members
Ass. Prof Natividad Ruiz, Department of Microbiology, The Ohio State University, USA.
Research focus on the transport of essential glycolipids across cell envelope compartments in E.coli. Contributions to the field of envelope biogenesis include the identification and characterization of proteins that are required for the biogenesis of outer membrane f3-barre l proteins, lipopolysaccharides, and the peptidoglycan cell wall.
Prof Hans-Georg Sahl, Institut fur Pharmezeutische Mikrobiologie, Universitat Bonn, Germany.
Current speaker of a basic research consortium " Post-Genomic Strategies for New Antibiotic Drugs and Targets" sponsored by the German ResearchFoundation (DFG). Head of the translational research unit "Novel Anti-infectives" of
the German Centre of Infection Research (DZIF).
Prof Chris Whitfield, Department of Molecular and Cellular Biology, University of Guelph, Canada.
Research group's activities include dissecting the machinery involved in the biosynthesis and export of these components using microbial cell biology and structural biology approaches, as well as actively pursuing small molecule inhibitors of key enzymes and exploiting some of the systems in vaccine development strategies. Extensive Scientific Advisory Board experience in both the academic and private sectors at national and international levels.
Research focus on the transport of essential glycolipids across cell envelope compartments in E.coli. Contributions to the field of envelope biogenesis include the identification and characterization of proteins that are required for the biogenesis of outer membrane f3-barre l proteins, lipopolysaccharides, and the peptidoglycan cell wall.
Prof Hans-Georg Sahl, Institut fur Pharmezeutische Mikrobiologie, Universitat Bonn, Germany.
Current speaker of a basic research consortium " Post-Genomic Strategies for New Antibiotic Drugs and Targets" sponsored by the German ResearchFoundation (DFG). Head of the translational research unit "Novel Anti-infectives" of
the German Centre of Infection Research (DZIF).
Prof Chris Whitfield, Department of Molecular and Cellular Biology, University of Guelph, Canada.
Research group's activities include dissecting the machinery involved in the biosynthesis and export of these components using microbial cell biology and structural biology approaches, as well as actively pursuing small molecule inhibitors of key enzymes and exploiting some of the systems in vaccine development strategies. Extensive Scientific Advisory Board experience in both the academic and private sectors at national and international levels.
